BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25348707)

  • 41. Biomarkers of kidney injury.
    Urbschat A; Obermüller N; Haferkamp A
    Biomarkers; 2011 Jul; 16 Suppl 1():S22-30. PubMed ID: 21707441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of novel biomarkers in early diagnosis and prognosis of acute kidney injury in newborns.
    Argyri I; Xanthos T; Varsami M; Aroni F; Papalois A; Dontas I; Fanos V; Iacovidou N
    Am J Perinatol; 2013 May; 30(5):347-52. PubMed ID: 23023560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary L-FABP and its combination with urinary NGAL in early diagnosis of acute kidney injury after cardiac surgery in adult patients.
    Liu S; Che M; Xue S; Xie B; Zhu M; Lu R; Zhang W; Qian J; Yan Y
    Biomarkers; 2013 Feb; 18(1):95-101. PubMed ID: 23167703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kidney damage biomarkers: Novel tools for the diagnostic assessment of acute kidney injury in cirrhosis.
    Wong F; Murray P
    Hepatology; 2014 Aug; 60(2):455-7. PubMed ID: 24700173
    [No Abstract]   [Full Text] [Related]  

  • 45. Tubular biomarkers to assess progression of diabetic nephropathy.
    Tramonti G; Kanwar YS
    Kidney Int; 2011 May; 79(10):1042-4. PubMed ID: 21527942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum and urinary NGAL but not KIM-1 raises in human postrenal AKI.
    Urbschat A; Gauer S; Paulus P; Reissig M; Weipert C; Ramos-Lopez E; Hofmann R; Hadji P; Geiger H; Obermüller N
    Eur J Clin Invest; 2014 Jul; 44(7):652-9. PubMed ID: 24837251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
    Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S
    Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emerging biomarkers of acute kidney injury.
    Devarajan P
    Contrib Nephrol; 2007; 156():203-12. PubMed ID: 17464129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biomarkers in acute kidney injury: are we ready for prime time?
    Devarajan P; Murray P
    Nephron Clin Pract; 2014; 127(1-4):176-9. PubMed ID: 25343845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of poor outcomes with novel and traditional biomarkers at clinical AKI diagnosis.
    Hall IE; Coca SG; Perazella MA; Eko UU; Luciano RL; Peter PR; Han WK; Parikh CR
    Clin J Am Soc Nephrol; 2011 Dec; 6(12):2740-9. PubMed ID: 22034509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hsp72 is a novel biomarker to predict acute kidney injury in critically ill patients.
    Morales-Buenrostro LE; Salas-Nolasco OI; Barrera-Chimal J; Casas-Aparicio G; Irizar-Santana S; Pérez-Villalva R; Bobadilla NA
    PLoS One; 2014; 9(10):e109407. PubMed ID: 25313566
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New biomarkers for acute renal injury.
    Soni SS; Pophale R; Ronco C
    Clin Chem Lab Med; 2011 Aug; 49(8):1257-1263. PubMed ID: 21726165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urine NGAL and KIM-1 in children and adolescents with hyperuricemia.
    Tomczak J; Wasilewska A; Milewski R
    Pediatr Nephrol; 2013 Sep; 28(9):1863-9. PubMed ID: 23673972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of urinary kidney injury molecule-1 and interleukin-18 in the early post-burn period to predict acute kidney injury for various degrees of burn injury.
    Ren H; Zhou X; Dai D; Liu X; Wang L; Zhou Y; Luo X; Cai Q
    BMC Nephrol; 2015 Aug; 16():142. PubMed ID: 26283194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation.
    Hall IE; Yarlagadda SG; Coca SG; Wang Z; Doshi M; Devarajan P; Han WK; Marcus RJ; Parikh CR
    J Am Soc Nephrol; 2010 Jan; 21(1):189-97. PubMed ID: 19762491
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary neutrophil gelatinase-associated lipocalin accurately detects acute allograft rejection among other causes of acute kidney injury in renal allograft recipients.
    Heyne N; Kemmner S; Schneider C; Nadalin S; Königsrainer A; Häring HU
    Transplantation; 2012 Jun; 93(12):1252-7. PubMed ID: 22513480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tubular Injury Biomarkers to Detect Gentamicin-Induced Acute Kidney Injury in the Neonatal Intensive Care Unit.
    Jansen D; Peters E; Heemskerk S; Koster-Kamphuis L; Bouw MP; Roelofs HM; van Oeveren W; van Heijst AF; Pickkers P
    Am J Perinatol; 2016 Jan; 33(2):180-7. PubMed ID: 26344007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary biomarkers for the detection of renal injury.
    Rosner MH
    Adv Clin Chem; 2009; 49():73-97. PubMed ID: 19947356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma.
    Morrissey JJ; London AN; Lambert MC; Kharasch ED
    Am J Nephrol; 2011; 34(5):391-8. PubMed ID: 21912102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.